Clinical Trial Update: A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and Bevacizumab [Phase 2]

View source ↗

Summary

This entry describes a Phase 2, single-arm trial evaluating cabozantinib in hepatocellular carcinoma patients who have received prior atezolizumab and bevacizum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Chulalongkorn University | Conditions: Hepatocellular Carcinoma Non-resectable | Phase 2 | Status: NOT_YET_RECRUITING